Bayer Overview

  • Founded
  • 1863

Founded

  • Status
  • Public

  • Employees
  • 102,048

Employees

  • Stock Symbol
  • BAYN

Stock Symbol

  • Investments
  • 83

  • Share Price
  • $48.38
  • (As of Tuesday Closing)

Bayer General Information

Description

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Contact Information

Website
www.bayer.com
Formerly Known As
Farbenfabriken Bayer, Farbenfabriken Bayer AG, Friedr. Bayer et comp.
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Conglomerates
Other Industries
Pharmaceuticals
Agricultural Chemicals
Drug Discovery
Stock Exchange
ETR
Primary Office
  • Kaiser-Wilhelm-Allee 1
  • 51373 Leverkusen
  • Germany
+49 0214 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$48.38 $49.31 $45.11 - $70.36 $47.5B 982M 2M $1.55

Bayer Financials Summary

In Thousands,
USD 		TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 92,783,072 85,901,992 91,387,581 91,131,991
Revenue 50,972,596 53,347,142 52,116,906 47,192,395
EBITDA 11,859,494 11,048,144 8,347,028 (13,300,504)
Net Income 1,515,136 4,363,323 1,182,299 (11,963,386)
Total Assets 132,220,870 133,917,790 136,139,354 143,665,055
Total Debt 50,552,066 44,311,467 44,757,818 51,113,735
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bayer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer‘s full profile, request access.

Request a free trial

Bayer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and
Conglomerates
Leverkusen, Germany
102,048 As of 2023
000.00
000000000 000.00

000000

ng elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut e
0000 000000000
Gaithersburg, MD
0000 As of 0000
00.000
000000000 00 00.000

00000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. D
000000000000000
Darmstadt, Germany
00000 As of 0000
00.00
000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bayer Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Emergent BioSolutions Corporation Gaithersburg, MD 0000 00.000 000000000 00 00.000
00000 Corporation Darmstadt, Germany 00000 00.00 000000000 00.00
0000000 Formerly VC-backed Ness Ziona, Israel 000 00000 000000000 00000
000000 00000 Corporation Mumbai, India 0000 00000000
To view Bayer’s complete competitors history, request access »

Bayer Patents

  • 162,893

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1,435

    Granted

  • 4,829

    Pending

  • 000

    Expiring in next 12 mo

Bayer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4245135-A1 Conducting and documenting an application of plant protection agents Pending 16-Mar-2022 0000000000
EP-4108650-A1 Method for separating azeotropic mixtures Inactive 08-Mar-2022 0
EP-4238972-A1 Substituted 1,2,4-thiadiazolyl picolinamides, salts or n-oxides thereof and their use as herbicidally active substances Pending 04-Mar-2022 0000000000 00
EP-4238973-A1 Substituted 1,2,4-thiadiazolyl isonicotinamides, salts or n-oxides thereof and their use as herbicidally active substances Pending 04-Mar-2022 0000000000 00
EP-4235455-A1 Semantic search tool Pending 28-Feb-2022 G06F16/3347 0
To view Bayer’s complete patent history, request access »

Bayer Executive Team (54)

Name Title Board Seat Contact Info
William Anderson Chief Executive Officer & Chairman
Sebastian Guth Ph.D President, Bayer U.S. President, Pharmaceuticals North America
Rodrigo Santos President of Crop Science Division & Member of the Board of Management
Johannes Dietsch Chief Financial Officer and Member of the Board of Management
Jana Ackermann Chief Financial Officer, Brazil
You’re viewing 5 of 54 executive team members. Get the full list »

Bayer Board Members (40)

Name Representing Role Since
0000000 0000000 Self Member of the Supervisory Board, Member of Audit Committee & Member of Nomination Committee 000 0000
00000 000 000000 Self Member of the Supervisory Board, Member of Human Resources and Compensation Committee, Chairman of the Bayer Group Works Council & Chairman of the Works Council of the Dormagen site, Member of Innovation & ESG Committee 000 0000
000000 000000 Bayer Member of the Supervisory Board, Vice Chairwoman of the Bayer Central Works Council & Chairwoman of the Works Council of the Berlin site, Member of Human Resources and Compensation Committee & Member of Innovation Committee 000 0000
0000000 0000000000 Bayer Member of the Supervisory Board, Chairwoman of the Bayer Group Executives' Committee, Chairwoman of the Executives' Committee of Bayer AG, Wuppertal & Member of Audit Committee 000 0000
0000000 0000000 Self Member of the Supervisory Board, Independent Consultant, Member of Nomination Committee & ESG Committee 000 0000
You’re viewing 5 of 40 board members. Get the full list »

Bayer Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bayer Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer‘s full profile, request access.

Request a free trial

Bayer Investments & Acquisitions (83)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 21-Sep-2023 000000000 Buildings and Property 0000 0000
0000000 (0000 23-Jan-2023 0000000000 Media and Information Services (B2B)
000000000 000 18-Jan-2023 0000000000 Enterprise Systems (Healthcare) 000000 00
0000000000 10-Nov-2022 0000000000 Biotechnology
CoverCress 01-Aug-2022 Merger/Acquisition Cultivation 0000000 0
You’re viewing 5 of 83 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Bayer Subsidiaries (19)

Company Name Industry Location Founded
Corea Therapeutics Biotechnology Tucson, AZ 2019
00000000 000000000 Drug Discovery Cambridge, MA 0000
0000000 Other Pharmaceuticals and Biotechnology New York, NY 0000
00000 00 00000 Corporate Venture Capital Leverkusen, Germany 0000
0000000000 Biotechnology Potsdam, Germany 0000
You’re viewing 5 of 19 subsidiaries. Get the full list »

Bayer ESG

Risk Overview

Risk Rating

Updated April, 25, 2023

27.44 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,491

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 871

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 415

Rank

00.00

Percentile

To view Bayer’s complete esg history, request access »

Bayer Exits (21)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000 06-Jan-2021 00000 00000 00 00000 Completed
  • 21 buyers
00000 00000000 26-Nov-2019 00000 00000 00 000.00 Completed
  • 3 buyers
0000000 02-Jul-2018 0000 00000 00.00 Completed
  • 11 buyers
0000 000 14-Sep-2017 00000 0000000 00000 Completed
  • 4 buyers
xarvio 01-Dec-2015 Merger/Acquisition Completed
You’re viewing 5 of 21 exits. Get the full list »